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Abstract
The homeodomain-interacting protein kinase (HIPK) family is comprised of four highly related serine/threonine kinases
originally identified as co-repressors for various homeodomain-containing transcription factors. The HIPKs have been shown
to be involved in growth regulation and apoptosis, with numerous studies highlighting HIPK regulation of the tumor
suppressor p53. In this study, we have discovered a B cell homeostatic defect in HIPK1-deficient (HIPK1
2/2) mice.
Lymphopoietic populations within the thymus and bone marrow of HIPK1
2/2 mice appeared normal based upon FACS
analysis; however, the spleen exhibited a reduced number of total B cells with a significant loss of transitional-1 and
follicular B cell populations. Interestingly, the marginal zone B cell population was expanded in HIPK1
2/2 mice, yielding an
increased frequency of these cells. HIPK1
2/2 B cells exhibited impaired cell division in response to B cell receptor cross-
linking in vitro based upon thymidine incorporation or CFSE dilution; however, the addition of CD40L rescued HIPK1
2/2
proliferation to wild-type levels. Despite the expanded MZ B cell population in the HIPK1
2/2 mice, the T-independent type 2
humoral response was impaired. These data identify HIPK1 as a novel kinase required for optimal B cell function in mice.
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Introduction
The murine splenic B cell population is a heterogeneous
population comprised of developing B cells as well as subsets of
mature B cells. While the vast majority of splenic B cells are
follicular (FO), only 5–10% are marginal zone (MZ) B cells [1,2].
Broadly speaking, FO B cells respond to thymus-dependent (TD)
antigens, however, they recently have been shown to also
participate in T cell-independent responses in the bone marrow
(BM) [3,4]. MZ B cells are localized near the marginal sinus,
between the white and red pulp, and are thus in a prime location
to function as the first line of defense against blood-borne
pathogens [2,5,6]. MZ B cells produce natural antibodies, and
resemble memory cells in that they have an activated phenotype,
they self-renew and have an unlimited lifespan. FO B cells, in
contrast, have a lifespan of weeks. The mechanisms underlying the
fate decisions controlling FO and MZ development remain
elusive. MZ B cell development requires Delta-like 1 (DL1) and
B cell activating factor (BAFF) signaling, as well as chemotactic
and integrin signaling (reviewed [6]). Several studies have also
identified a role for B cell receptor (BCR) signal strength in
determining the FO versus MZ fate decision [2,7,8].
Two hypotheses have emerged to explain what drives
commitment to the MZ B cell fate: the ‘‘production bottleneck’’
hypothesis and the ‘‘signal strength’’ hypothesis. The splenic MZ
population is preferentially maintained in the absence of B cell
influx from the BM [9,10,11], and several genetic mouse models
have reported enlarged splenic MZ compartments in the context
of impaired early B lymphopoiesis [2]. The ‘‘production
bottleneck’’ hypothesis conjectures that this phenomenon arises
as a compensatory mechanism that favours the development of the
effector branch of the B cell system when B lymphopoiesis is
impaired [2]. MZ B cells are considered to be the effector branch
due to their activated phenotype and their ability to rapidly
produce natural IgM. In contrast, the ‘‘signal strength’’ hypothesis
argues that the strength of the BCR signal regulates commitment
to the FO and MZ B cell fates [2,7,8]. Weak BCR signaling
preferentially commits developing B cells to the MZ B cell fate,
whereas strong BCR signals favour the FO B cell fate [2,6].
The homeodomain-interacting protein kinase (HIPK) family is
comprised of four evolutionarily conserved and highly related
nuclear serine/threonine kinases [12,13]. Structurally, HIPKs
possess a homeoprotein-interaction domain, kinase domain, PEST
domain, a tyrosine/histidine-rich (YH domain) C-terminus, as well
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were originally identified as co-repressors for various homeodo-
main-containing transcription factors [13]. HIPK4 was discovered
in the human genome sequence based on its high homology to the
other members of the HIPK family [12]. HIPK4 is a truncated
version of the kinase, which lacks the homeoprotein-interaction
domain making it 616 amino acids, and is primarily cytoplasmic in
its localization [17,18]. The HIPKs interact with a variety of
proteins involved in regulating cellular stress responses. During the
DNA damage response HIPK2 phosphorylates Ser46 of p53,
which facilitates cyclic AMP response element-binding (CREB)-
binding protein (CBP)-mediated acetylation of p53 at Lys382,
leading to p53-dependent gene expression [19–21]. In addition to
p53, HIPK2 interacts with several other proteins involved in
apoptosis and proliferation, including p63 and p73 [19,20,22],
Brn3a [23], c-Ski [24], CtBP [25,26], and components of the Wnt
pathway [27–35]. Like HIPK2, HIPK1 is also a p53 kinase,
however the site of phosphorylation is unknown [12,36]. In
addition to modulation of p53-induced apoptosis, HIPK1 has been
implicated in controlling apoptosis signal-regulating kinase (ASK)-
1-induced apoptosis [16,37,38]. These studies suggest that at least
one of the functions of the HIPK family is to regulate growth and
apoptosis pathways. Deletion of either HIPK1 or HIPK2 does not
affect viability in mice; however, deletion of both HIPK1 and
HIPK2 is embryonic lethal with fetal death at embryonic day 9.5–
12.5 due to a neural tube closure defect (NTD), demonstrating a
functional requirement for HIPK activity in developing tissues
[39]. The high expression of HIPK1 in cells of the hematopoietic
lineage relative to non-hematopoietic cells suggests HIPK1 may
play a significant role in hematopoietic cell development and/or
function.
In the present report, we have analyzed the role of HIPK1 in
the B cell compartment using HIPK1-deficient (HIPK1
2/2) mice
[36]. Our phenotypic analysis of HIPK1
2/2 mice has revealed a
splenic B cell homeostatic defect resulting in a reduced number
of total splenic B cells, but an increase in the MZ B cell popula-
tion. Despite the expanded MZ B cell population, HIPK1
2/2
mice exhibited a significantly impaired T-independent type 2
(TI-2) humoral response. Based on our studies, we have iden-
tified a requirement for HIPK1 in splenic B cell homeostasis and
activation.
Materials and Methods
Ethics Statement
Animals were maintained in pathogen-free conditions at the
Ontario Cancer Institute and the Max-Bell Institute under
University Health Network Animal Resource Centre guidelines
(permit 1292.8).
Mice
HIPK1
2/2 mice were a gift from T.W. Mak (Campbell Family
Cancer Research Institute and Ontario Cancer Institute, Toronto,
ON) and have been described previously [36]. HIPK1
2/2 mice
were backcrossed to C57/Black6 one additional generation to
generate heterozygous offspring, which were then intercrossed to
obtain HIPK1
+/+ and HIPK1
2/2 mice for further propagation and
analysis. Mice were age- and sex-matched for all experiments.
HIPK1
+/+ and HIPK1
2/2 genotypes were determined by poly-
merase chain reaction (PCR) amplification of tail DNA. Tail
clippings were digested overnight at 55uC in a digesting solution
containing 10 mM EDTA, 20 mM Tris, 10% SDS and 25 mg/ml
Proteinase K (Invitrogen, Burlington, ON). DNA was purified
using the DNeasy Purification Kit (Qiagen, Mississauga, ON), and
diluted 1/10 for use in PCR reactions. The primers used to
identify a hipk1 fragment of ,350 base pairs were 59-
ACCTGCTGCAAGATTGGTCT-39 (sense) and 59-AGTGTC-
GTCGAGTGCCTTCT-39 (antisense). To identify a neo fragment
of ,150 base pairs the following primers were used: 59-
GGCGCGAGCCCCTGATGCTC-39 (sense) and 59-TTGGG-
TGGAGAGGCTATTCGGCTATGAC-39 (antisense). The hipk1
PCR reaction was as follows: Step 1: 94uC for 5 min. Step 2,
repeated 30 cycles: 94uC for 30 s, 61uC for 1 min., 72uC for
1 min. Step 3: 72uC for 5 min. The neo PCR reaction was as
follows: Step 1: 94uC for 5 min. Step 2, repeated 30 cycles: 95uC
for 1 min., 62uC for 1 min., 72uC for 1 min. Step 3: 72uC for
5 min. PCR products were run on a 1.5% agarose gel. Mice age
ranged from 8 to 12 weeks.
Chemicals
Unless otherwise indicated, all chemicals were purchased from
Sigma.
HIPK1 expression in lymphocytes
Primary B cells were purified from the spleens of HIPK1
+/+ and
HIPK1
2/2 mice using the autoMACS system (described below).
Total RNA was extracted using an RNeasy Kit (Qiagen,
Mississauga, ON) and reverse transcribed to cDNA using random
hexamers. Serial dilutions of the cDNA were used for the PCR
reactions. The primers used to generate the hipk1 fragment were
described in the genotyping protocol (see above). The primers for
gapdh amplification were 59-ACCACAGTCCAT GCCATCAC-39
(sense) and 59-TCCACCACCCTGTTGCTGTA-39 (antisense).
The PCR programs were as follows: hipk1 (see above). gapdh: Step
1: 94uC for 5 min. Step 2, repeated for 27 cycles: 94uC for 40 s,
56uC for 45 s, 72uC for 40 s. Step 3: 72uC for 10 min. The PCR
products were subjected to electrophoresis on 1% agarose gels.
Primary lymphocyte isolation and culture
Peritoneal cells were recovered by injecting 5 ml of PBS into the
peritoneum of an euthanized mouse and gently massaging the
peritoneal cavity before recovering the solution and cells. T cell
progenitors were recovered from the thymus of euthanized mice.
Single cell suspensions were prepared for cell counting and for
FACS analysis using a 70 mM mesh filter (VWR, Mississauga,
ON). B lineage progenitors were recovered from the BM of tibia
and femurs from euthanized mice using a 26 gauge needle to flush
out the BM. Single-cell suspensions were prepared from BM or
spleens, and the red blood cells (RBCs) were lysed in 1 ml/spleen
ACK solution (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM
EDTA, brought to pH 7.0 using 1 N HCl). Cells were maintained
at 37uC in a humidified atmosphere containing 5% CO2 during
stimulations.
Magnetic cell sorting on the autoMACS Separator (Miltenyi
Biotec, Auburn, CA) was used to enrich the B cell population using
the B cell Purification Kit according to the manufacturer’s
instructions (Miltenyi Biotec). Briefly, ACK-treated splenocytes
were incubated with a cocktail of biotin-conjugated antibodies
against CD43, CD4 and Ter119 for 15 min. at 4uC. Anti-biotin
microbeads were then added and incubated for an additional
15 min. at 4uC. Cells were then washed and resuspended with the
provided buffers. The microbeads bound to the magnetic column
and prevented any splenocytes expressing CD43, CD4 or Ter119
from passing though. The depletion of these cells yielded 98%
CD19
+ cells in the subsequent flow-through. Purified B cells were
cultured in RPMI medium (Invitrogen) containing 10% fetal
bovine serum (FBS), 50 mM beta-mercaptoethanol, 50Units/L
penicillin, 50 mg/L streptomycin and 10 mM HEPES. Cells were
HIPK1 in B Cells
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CO2 during stimulations.
Flow cytometry
For flow cytometry the following biotin-, FITC-, phycoerythrin
(PE)-, (PerCP)- and allophycocyanin (APC)-labeled antibodies
were purchased from BD Biosciences (San Diego, CA): anti-B220
(RA3-6B2), anti-CD43 (S7), anti-BP.1 (6C3), anti-HSA (M1/69),
anti-CD4 (GK1.5), anti-CD8 (53-6.72), anti-CD25 (7D4), anti-
CD44 (1M7), anti-CD3 (145-2C11), anti-IgD (SBA.1), anti-CD21
(7G6), anti-CD23 (B3B4), CD1d (1B1) and AnnexinV. Anti-IgM
(II/41; R6-60.2) was purchased from eBioscience. Cells were
washed in FACS Solution (PBS, 1% FCS and 0.1% NaN3), and
incubated at 5610
7 cells/ml with FACS antibodies for 25 min. at
4uC. After staining, cells were washed twice in FACS Solution, and
resuspended in approximately 400 ml of FACS Solution. In some
staining, propidium iodide (PI)(Sigma) or 7-amino-actinomycin D
(7AAD)(Sigma) were used to identify dead cells. All samples were
analyzed on a FACSCalibur instrument (BD, Mississauga, ON)
and the data was then analyzed using FloJo software (Tree Star,
Ashland, OR).
To detect caspase-3 positive T1 B cells, total splenocytes were
isolated from HIPK1
+/+ and HIPK1
2/2 mice and immediately
incubated with FITC-DEVD-FMK (EMDBiosciences, Missis-
sauga, ON) according to the manufacturer’s instructions. The
splenocytes were then stained with B220, CD23, and CD21 so
that T1 B cells could be identified. 90 000 total events were
acquired.
Antigen receptor activation of primary B cells
Purified B cells were plated at 1610
6 cells/ml, and stimulated
with F(ab9)2 anti-mouse IgM (10 mg/ml; Jackson Immunoresearch,
West Grove, PA) with or without CD40L (10 mg/ml; 1C10,
Southern Biotech, Birmingham, AL) for the indicated amounts of
time.
Proliferation Assays
For thymidine incorporation assays, cells were pulsed with
1 mCi [
3H] thymidine 12 hrs before the desired time point. The
cells were harvested onto 96-well plates containing fiber filters and
the incorporated thymidine was measured using the TopCount
liquid scintillation counter (Canberra/Packard, Mississauga, ON).
For the cell division assay, Cell Tracker Green 5-chloromethyl-
fluorescein diacetate (CFSE)(Molecular Probes, Burlington, ON)
was used according to the manufacturer’s recommendations.
Briefly, cells were stained in 5 mM CFSE in PBS at 37uC for
5 min. with periodic, gentle swirling. Cells were then resuspended
in 4 ml FBS and pelleted at 4006g at 4uC. Cells were then washed
twice with cold PBS before analysis. FloJo Proliferation Platform
(Treestar) was used to analyze the results of the cell division assay.
Immunoprecipitation and Western Blotting
Cell pellets were lysed in a kinase lysis buffer (20 mM Tris-HCl
pH7.5, 150 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycho-
late, 1% NP-40), containing fresh 1 mM sodium orthovanadate,
50 mM NaF, 1 mM phenylmethylsulfonyl fluoride and 16
ETDA-free protease inhibitor cocktail (Roche, Laval, PQ) for
10 min. on ice. The lysates were then clarified by centrifugation
at 16, 0006g at 4uC. For immunoprecipitation, lysates were first
pre-cleared with Protein G beads (Invitrogen) for 45 min. on a
nutator. The pre-cleared lysates were then incubated with the
capturing antibody for 2 hrs at 4uC on a nutator. Beads that had
been blocked with PBS containing 1% BSA were then added to
the lysates for one hour. The beads were washed three times with
kinase lysis buffer, then bound proteins were eluted using 26
sample buffer and boiling at 95uC for five min. The lysates and
immunoprecipitates were resolved on 8–10% SDS-PAGE and
transferred to Immobilon membranes (Milipore, Jaffrey, NH).
Anti-Actin antibody was purchased from Sigma. Antibodies for
phospho-Akt (Ser473), Akt, phospho-Erk1/Erk2, Erk1/Erk2,
PLCc, phospho-Btk, Btk, and Syk were purchased from Cell
Signaling Technology (Danvers, MA). 4G10 antibodies were
purified from hybridoma supernatant and used to detect
phospho-tyrosine residues. Immunoreactive proteins were detect-
ed using the ECL and ECLplus detection systems (GE
Healthcare, UK).
Immunohistochemistry
Spleens were removed and snap-frozen in OCT compound
(Thermo Shandon, Pittsburgh, PA). Sections were generated using
a Leica 3050S cryostat (Leica, Wetzlar, Germany), and frozen
sections were fixed in ice-cold acetone for 10 min. Spleen sections
were first incubated with blocking solution (10% rabbit serum,
10% mouse serum, ‘‘Fc block’’ 2.4G2 antibodies in Tris-buffered
saline-0.05% Tween 20 (Sigma)) and then stained with biotiny-
lated anti-IgM (Vector Laboratories Inc, Burlington, ON) and
fluorescein isothiocyanate (FITC)-anti-IgD (eBioscience, San
Diego, CA) or FITC-anti-MAdCAM1 (MECA-367)(eBioscience).
Sections were then stained with the secondary antibodies
streptavidin-conjugated horseradish peroxidase (HRP) (Prozyme,
San Leandro, CA) and anti-FITC-conjugated alkaline phospha-
tase (Roche Diagnostics Canada). The sections were developed
using the Vector HRP development kit, followed by the Vector
alkaline phosphatase substrate kit III, both as per the manufac-
turer’s instructions (Vector Laboratories Inc). Sections were
mounted with Crystal/Mount (Biomeda Corp., Foster City, CA)
and visualized on a Leica upright DMRA2 microscope.
Immunization and ELISA
For the trinitrophenylated-Ficoll (TNP-Ficoll; Biosearch Tech-
nologies, Novato, CA) immunization, 25 mg of TNP-Ficoll
dissolved in phosphate buffered saline (PBS) were administered
intraperitoneally (i.p.) to age-matched, male HIPK1
+/+ and
HIPK1
2/2 mice. Blood was collected at the indicated time points
by lateral tail-vein bleeds, and serum was isolated using Gel
Activator serum separation tubes (Sarstedt, Montreal, PQ). To
measure the TI-2 humoral response, serum from TNP-Ficoll-
immunized mice was incubated on ELISA plates coated with
TNP-BSA. TNP-specific IgM and IgG3 antibodies were detected
using secondary anti-IgM-HRP and anti-IgG3-HRP detection
antibodies (Southern Biotech). To detect basal serum Ig, plates
were coated with a capturing anti-mouse Ig overnight. Serial
dilutions of serum were then incubated overnight, and detected
the following day using HRP-conjugated anti-IgG1, -IgG2b,
-IgG2c, -IgG3, -IgA or –IgM (Southern Biotech).
Elispot
Age- and sex-matched mice were immunized i.p. with 25 mg
TNP-Ficoll. Seven days later, the spleens were harvested and
single-cell suspensions were prepared. After RBC lysis, the cells
were counted using a hemocytometer and, starting with an equal
concentration of cells in the HIPK1
+/+ and HIPK1
2/2 samples,
serial dilutions were plated on TNP15-BSA-coated PVDF-
bottomed plates. The plates had been coated with TNP15-BSA
overnight at 4uC and then blocked with 5% BSA for three hrs at
37uC prior to plating the splenocytes. The cells were incubated in
the plates for 3 hrs at 37uC with no movement. The plates were
HIPK1 in B Cells
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incubated with isotype-specific HRP-conjugated antibodies (see
above) for one hr at room temperature. The plates were then
washed and AEC Chromogen (BD Biosciences) was added as the
HRP substrate in order to generate an insoluble precipitate.
Finally, the plates were air-dried and maintained in the dark until
they were imaged and analyzed using a Cellular Technology Ltd
(CTL) Immunospot plate reader (CTL, Shaker Heights, OH).
Statistics
To calculate p values, data were analyzed by the unpaired
student t test unless otherwise indicated. *p#0.05, **p#0.01,
***p#0.001.
Figure 1. HIPK1 is expressed in hematopoietic cells. A, Analysis of the tissue-specific gene expression profiles of hipk1 and hipk2 using the
BioGPS-Gene Portal Hub web application (Genomics Institute of the Novartis Research Foundation (GNF). For this study, B and T lymphocytes were
obtained from spleen. B, Primary B and T lymphocytes were isolated from the spleens of HIPK1
+/+ (WT) and HIPK1
2/2 (KO) mice. mRNA was isolated
and reverse transcribed to cDNA. PCR amplification was used to determine if hipk1 was expressed. gapdh was used as a control.
doi:10.1371/journal.pone.0035533.g001
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2/2 mice exhibit normal T cell development in thymi. A, Thymic cellularity was similar between HIPK1
+/+ and HIPK1
2/2 mice at
4–5 weeks and 8–13 weeks. For 4–5 week old mice, n=7; for 8–13 week old mice, n=13. B, CD4 and CD8 expression was used to identify the
frequency of double-positive (DP) and single positive populations, and did not reveal any abnormalities. FACS analysis of thymocyte subsets using
CD44 and CD25 expression indicated that the double-negative DN I–IV populations were intact in HIPK1
2/2 mice. Representative FACS plots are
shown (n=9).
doi:10.1371/journal.pone.0035533.g002
Figure 3. HIPK1
2/2 mice exhibit normal B cell development in the bone marrow. A, FACS analysis of bone marrow. Bone marrow was
isolated, ACK-treated and stained with B220, IgM, BP.1, CD43, HSA and IgD in order to determine the frequencies of developing B cell subsets;
representative FACS plots are shown (n=8).
doi:10.1371/journal.pone.0035533.g003
HIPK1 in B Cells
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2/2 mice. A, Mice were weighed after being sacrificed. Spleens were then excised and weighed, and
expressed as a percentage of the total mouse weight (n=16). B, The number of splenocytes obtained after ACK-treatment was counted using a
HIPK1 in B Cells
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HIPK1 is expressed in cells from the hematopoietic
lineage
Analysis of the tissue-specific gene expression profiles of hipk1
and hipk2 using the BioGPS-Gene Portal Hub web application
(Genomics Institute of the Novartis Research Foundation (GNF)
revealed that hipk1 is highly expressed in hematopoietic cells
(Figure 1A). We verified the expression of hipk1 in purified primary
B cells and T cells by PCR amplification of cDNA (Figure 1B).
hipk1 expression was detected in wild-type primary B and T cells,
but was absent in HIPK1
2/2 samples.
HIPK1 is not required for T cell development in the
thymus or B cell development in the BM
Based upon the high expression of HIPK1 in lymphocytes
(Figure 1A), lymphocyte subsets from primary lymphoid organs of
HIPK1
2/2 mice were analyzed for developmental abnormalities.
Thymic cellularity was normal in HIPK1
2/2 mice (Figure 2A).
FACS analysis of thymocyte subsets using CD4, CD8, CD44, and
CD25 expression indicated that the double-negative I–IV, double-
positive and single-positive populations were intact in the
HIPK1
2/2 mice, (Figure 2 A, B). Although there was a subtle
increase in the CD8 single-positive population in the HIPK1
2/2
mice, this difference was not statistically significant. To analyze the
frequency of B cell progenitor populations in the BM, gated B220
+
cells were separated into either CD43
+ or CD43
2 populations
(Figure 3A). B220
+CD43
+ cells were then analyzed for the
expression of HSA and BP.1 to determine relative frequencies of
Hardy fractions (Fr.) A (HSA
2BP.1
2), Fr. B (HSA
+BP.1
2) or Fr. C
(HSA
+BP.1
+). B220
+CD43
2 cells were analyzed for the expression
of IgM and IgD to determine relative frequencies of Hardy Fr. D
(IgM
2IgD
2), Fr. E (IgM
+IgD
2), or Fr. F (IgM
+IgD
+). These
analyses demonstrated that there were no developmental abnor-
malities within the BM B cell lineage as measured by the steady
state frequencies of B cell subsets in the HIPK1
2/2 derived BM.
HIPK1 is required for splenic B cell homeostasis
Mild splenomegaly was observed in the absence of HIPK1.
When spleen weight was expressed as a percentage of total body
weight, wild-type mice yielded an average value of 0.242%60.011
compared to HIPK1
2/2 mice which yielded an average value of
0.328%60.019 (Figure 4A). RBC lysis resulted in a reduction in
the overall cellularity of HIPK1
2/2 spleens, 102610
6610.74 cells/
spleen compared to 133610
668.38 cells/spleen in wild-type
controls (Figure 4B). The present study demonstrates that in the
absence of HIPK1, adult mice exhibit evidence of extramedullary
erythropoiesis. Hattangadi et al. have recently demonstrated that
HIPK2 plays an important role in terminal erythroid differenti-
ation [40], supporting a role for the HIPK family in erythroid
differentiation.
To investigate the cause of the reduced splenic cellularity, the
splenic lymphocyte populations were analyzed by flow cytometry.
The percentage of CD19
+ splenocytes was reduced in HIPK1
2/2
mice, resulting in 19.6862.04% CD19+ cells compared to
39.8964.16% in the HIPK1
+/+mice (Figure 4C). The percentage
of CD3+ splenocytes was subtly increased in the HIPK1
2/2 mice,
but no statistically significant differences were observed compared
to wild-type controls (Figure 4C). The percentage of splenic CD4
+
and CD8
+ T cells was also similar between HIPK1
2/2 mice and
wild-type controls (Figure 4D). The percentage of macrophages,
based on F480 and CD11b staining, was similar between HIPK1
2/2
and wild-type mice (Figure 4E). Using FSC, SSC, CD11c, CD4 and
CD8 as dendritic cell markers also revealed no abnormalities
(Figure 4E). These observations suggest that the reduced splenic
cellularity in the HIPK1
2/2 was largely due to decreased splenic B
cells.
Splenic B cells can be subdivided into transitional (T)-1 and T–
2, FO, and MZ B cells by differential surface expression of CD23,
CD21, IgM and IgD. FACS analysis of HIPK1
2/2 splenocytes
using FSC, CD23, CD21 and IgM surface markers revealed a
reduced percentage of T1 B cells and a 2.2-fold decrease in the
absolute number of T1 B cells compared to wild-type mice
(Figure 5A, B). This decrease was not attributable to decreased
viability of the T1 population (Figure S1). The T2 B cell
population, however, was unaffected by the absence of HIPK1
(Figure 5B). In contrast, HIPK1
2/2 mice exhibited an increase in
the MZ B cell population, which translated into a 1.9-fold increase
in their absolute numbers compared to wild type mice (Figure 5C).
The mature fraction of FO B cells was reduced by 1.6-fold in the
HIPK1
2/2 mice (Figure 5D). Due to the reduced absolute number
of splenic B cells in the HIPK1
2/2 mice, the 1.9-fold increase in
the absolute number of MZ B cells resulted in a 3.5-fold higher
frequency of MZ B cells (Figure 5E). Immunohistochemistry of
splenic sections stained with IgM and IgD revealed an expansion
of the MZ in the HIPK1
2/2 mice compared to wild-type mice,
consistent with our observation that MZ B cell numbers are
increased in HIPK1
2/2 mice (Figure 6). Analysis of peritoneal B1
B cells revealed no difference in the percentage of B1 B cells
between HIPK1
2/2 and wild-type mice (Figure 5F). Thus, HIPK1
is specifically required for normal B cell homeostasis in the spleen.
Based upon the disruption of the steady-state levels of the
splenic B cell populations, we investigated the basal serum
immunoglobulin (Ig) levels. Unstimulated adult HIPK1
2/2 mice
had similar basal levels of IgM, IgG1 and IgG3 compared to wild-
type controls (Figure 7). In contrast, IgA and IgG2b levels were
lower in HIPK1
2/2 mice compared to wild-type controls
(Figure 7A). It has been reported that MZ B cells switch to IgG2b
and IgA, with a particular propensity towards IgA compared to
FO B cells [41]. Thus, the reduced IgA and IgG2b levels in
HIPK1
2/2 mice may be a reflection of impaired MZ B cell
function, despite the expansion of this population. Interestingly,
the elevated IgG2c in the serum of the HIPK1
2/2 mice was not
accompanied by a decrease in the IgG1 levels and increase in
IgG3 levels, which is seen in response to IFN-c. Thus, the elevated
IgG2c is unlikely to be the result of cytokine skewing.
HIPK1 is required for optimal B cell proliferation in
response to BCR stimulation
The decreased number of splenic B cells in HIPK1
2/2 mice
prompted us to investigate the responsiveness of HIPK1
2/2 B cells
via BCR stimulation. Resting B cells were purified by negative
selection, yielding 98% B cell purity by B220 or CD19 staining
(not shown). The cells were then stimulated with anti-IgM 6
CD40L, or media alone for different intervals and then pulsed
with [
3H] thymidine. HIPK1
2/2 B cells exhibited impaired
hemacytometer (n=7). C–D, FACS was used to identify splenic populations. Representative FACS plots are shown; stains were performed in at least
three independent experiments with similar results unless indicated otherwise. C, CD3 was used to identify T cells, and CD19 to identify B cells (n=7).
D, CD4 and CD8 were used to identify splenic T cell subpopulations (n=6). E, CD11b and F480 were used to identify macrophages. CD11c, CD4 and
CD8 were used to identify dendritic cells (n=3). *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0035533.g004
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35533Figure 5. Splenic B cell homeostasis is disrupted in HIPK1
2/2 mice. A, Splenic B cells were stained using CD23, CD21, and IgM to distinguish
between B cell subsets. Representative FACS plots are shown for experiments that were conducted at least three times with similar results. B–D,
Frequencies obtained by FACS were converted to absolute numbers and averaged. B, The absolute number of T1 B cells was reduced in HIPK1
2/2 mice,
whereas the absolute number of T2 B cells was unaffected (n=6). C, The absolute number of MZ B cells was elevated in HIPK1
2/2 mice (n=6). D, The
absolute number of FO B cells was reduced in HIPK1
2/2 mice (n=7).E, TheMZ B cell populationexpressedas a percentage of the totalB cell population.
F, Cells obtained from peritoneal lavage were stained with CD5 and IgM to identify the B1 B cell population by FACS (n=6). *p#0.05, **p#0.01.
doi:10.1371/journal.pone.0035533.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35533proliferation in response to BCR stimulation (62% of the wild-type
response), whereas [
3H] thymidine incorporation was similar to
the wild-type response when CD40L was added (Figure 8A). To
determine whether the observed difference in [
3H] thymidine
incorporation was due to impaired cell division, cell division rates
were quantitatively measured using the CFSE dilution assay. Wild-
type and HIPK1
2/2 B cells were loaded with CFSE, stimulated
with anti-IgM 6 CD40L, and the fluorescence intensity of the dye
was measured over time. The viable HIPK1
2/2 B cell population
exhibited a distinct cell division lag at 72 hours post-stimulation
compared to wild-type B cells (Figure 8B). Only 21% of viable
HIPK1
2/2 B cells had undergone two or more divisions, whereas
48% of wild-type control B cells had undergone two or more
divisions (Table 1). The reduced rate of cell division in the
HIPK1
2/2 response to BCR cross-linking was rescued by CD40
co-stimulation. The viability of HIPK1
2/2 B cells following BCR
cross-linking was determined by AnnexinV and & 7-AAD staining,
and revealed no differences compared to wild-type controls
(Figure 8C).
HIPK1 is required for optimal humoral immunity to TI-2
antigen
Based upon the disruption of splenic B cell homeostasis in
HIPK1
2/2 mice, and their impaired response to antigen receptor
stimulation in vitro, the in vivo humoral immune response was
analyzed. Wild-type and HIPK1
2/2 mice were immunized with
the TI-2 antigen TNP-Ficoll, which elicits a largely MZ B cell-
dependent response. Following intraperitoneal injection of TNP-
Ficoll, serum TNP-specific antibodies were measured by ELISA at
Figure 6. Enlarged MZ compartment in HIPK1
2/2 mice. Splenic sections were stained with IgM (blue) and IgD (red) or MAdCAM1 (red) to
identify the MZ B cell population and the marginal sinus. Representative sections are shown, with similar results observed in three mice.
doi:10.1371/journal.pone.0035533.g006
Figure 7. Basal serum Ig levels. A, Basal serum Ig levels from 12
week-old HIPK1
+/+ and HIPK1
2/2 mice were measured by ELISA. n=4,
except for IgG2c, where n=8. *p#0.05, **p#0.01.
doi:10.1371/journal.pone.0035533.g007
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2/2 mice produced dramatically less TNP-
specific IgM and IgG3 antibodies compared to wild-type controls,
indicating that HIPK1 is required for an optimal humoural
response to TI-2 antigen (Figure 9A). In order to enumerate the
frequency of antibody producing B cells in HIPK1
2/2 spleens
following TI-2 antigen immunization, an ELISPOT assay was
conducted. Spleens derived from HIPK1
2/2 mice had fewer
antibody producing cells seven days after immunization compared
to spleens from wild-type controls (29.6965.26 versus
93.6962.69)(Figure 9B). Thus, fewer HIPK1
2/2 B cells were
activated and recruited into the response compared to wild-type
controls. This, despite HIPK1
2/2 mice having more MZ B cells,
suggests that HIPK1
2/2 MZ B cells poorly respond to antigen
receptor stimulation.
Signaling in the absence of HIPK1
Activation through the BCR results in complex downstream
signaling events. To investigate the biochemical defect causing the
impaired BCR proliferative response, signaling events following
BCR ligation were analyzed in wild-type and HIPK1
2/2 B cells.
Figure 8. HIPK1 is required for BCR-induced proliferation. A, Proliferation of HIPK1
+/+ and HIPK1
2/2 splenic B cells in response to anti-IgM 6
CD40L (10 mg/ml each) was assessed by [3H]-thymidine incorporation. Cultures were pulsed with 1 mCi tritiated thymidine 12 hrs before the
indicated time points. Representative results of three independent experiments are shown. B, Cell division of HIPK1
+/+ and HIPK1
2/2 splenic B cells
was determined by CFSE dilution assay. Cells were stimulated with anti-IgM 6 CD40L (10 ug/ml) or media alone, and analyzed at 24, 48, and 72 hrs
post-stimulation. The solid peaks are wild type and the empty peaks are HIPK1
2/2. FACS plots are representative of three independent experiments.
C, Viability was measured by FACS by gating on the AnnexinV and PI double-negative populations at 48 hrs after stimulation (n=4). *p#0.05.
doi:10.1371/journal.pone.0035533.g008
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activation. Anti-IgM-induced phosphorylation of Syk, Btk, Erk,
Akt and p38 were unaffected by the absence of HIPK1
(Figure 10A). PLC-c2 is responsible for the hydrolysis of
phosphatidylinositol-4,5-bisphosphate (PIP2), yielding inositol-
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), which facilitate
calcium release and protein kinase C (PKC) activation [42–44].
The phosphorylation of PLC-c2 was also unaffected by the
absence of HIPK1 (Figure 10A).
Discussion
The present study demonstrates that the serine/threonine
kinase HIPK1 is required for splenic B cell homeostasis, as well
as an optimal TI-2 humoral response. To date, the study of the
HIPKs has focused on their role in embryonic development and in
regulating cell survival and proliferation. This study is the first to
report a role for a member of the HIPK family in lymphocyte
function, in particular splenic B cell homeostasis and activation.
Our study of HIPK1
2/2 mice has revealed a unique role for
HIPK1 in splenic B cell homeostasis, a role that cannot be fully
compensated for by the other HIPK family members. Other
cellular constituents of the spleen including dendritic cells,
macrophages, and T cells were not affected by the absence of
HIPK1. We did, however, observe evidence of increased
extramedullary erythropoiesis in HIPK1
2/2 mice. This finding
together with the recent report that HIPK2 plays an important
role in terminal erythroid differentiation suggest that both HIPK1
and HIPK2 may be required for normal erythropoiesis [40].
The ‘‘signal strength’’ hypothesis argues that the strength of the
BCR signal can regulate commitment to the FO versus MZ B cell
fate [2,7,8]. Strong BCR signaling preferentially commits
developing B cells to the FO B cell fate, whereas weak BCR
Table 1. Impaired proliferation in response to BCR cross-
linking.
# of divisions .22 1 0
HIPK1
+/+ 20 28 18 9
HIPK1
2/2 31 8 3 0 2 2
FloJo Proliferation Platform (Tree Star) was used to analyze the percentage of
cells having undergone a given number of divisions at 72 hrs in response to
anti-IgM stimulation.
doi:10.1371/journal.pone.0035533.t001
Figure 9. HIPK1
2/2 mice exhibit an impaired TI-2 humoural
response. A, The TI-2 response was evaluated by measuring TNP-
specific IgM and IgG3 serum levels after i.p. immunization with 25 mg
TNP-Ficoll. Mice were bled at the indicated time points and serum
antibody isotypes were measured by ELISA, (n=5). B, Elispot analysis of
TNP-specific-IgM-producing cells in response to TNP-Ficoll seven days
post i.p. immunization (n=4). *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0035533.g009
Figure 10. BCR signaling in the absence of HIPK1. A, Primary B
cells were stimulated with anti-IgM (10 mg/ml) for the indicated
amounts of time and then lysed. Lysates were subjected to SDS-PAGE
and were probed with phospho-specific antibodies as indicated. Blots
are representative of minimally three independent experiments.
doi:10.1371/journal.pone.0035533.g010
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deficient in CD22, a negative regulator of BCR signaling, have a
reduced number of MZ B cells [45], whereas Aiolos deficient mice
have enhanced BCR signaling, and a concomitant reduction in the
number of splenic MZ B cells with increased numbers of FO B
cells [46,47]. The Aiolos phenotype can be suppressed by
intercrossing the Aiolos-deficient mice with Xid mice, which lack
a fully functional BTK tyrosine kinase. Attenuation of the BCR
signal in these mice restored the number of MZ B cells. These
observations support the hypothesis that ‘‘signal strength’’ is
involved in MZ B cell fate decisions. The size of the MZ pool,
however, does not necessarily correlate with the functionality of
the MZ B cells within this splenic region. For example, while the
lymphocyte adaptor protein (Lnk) transgenic mouse, the Friend
leukemia virus integration 1 (Fli-1)
DCTA mouse and IL7-deficient
mice have elevated MZ cell populations accompanied by an
enhanced response to TNP-Ficoll [48–50], 3BP2-deficient mice
have an increased MZ splenic compartment but manifest a poor
TI-2 response [51]. HIPK1
2/2 mice have normal BM B cell
development but reduced T1 and FO populations and an
expanded MZ B cell population; however, HIPK1
2/2 mice are
hyporesponsive to anti-IgM stimulation and immunization with
TI-2 antigen. Thus, the HIPK1
2/2 phenotype also supports the
role of weak BCR signaling in commitment to the MZ B cell fate.
B1 B cells function in a similar manner as MZ B cells in that
they are a source of natural antibodies, are rapidly activated, and
are involved in the TI-2 humoral response [52]. Though the
‘‘signal strength’’ hypothesis would predict a decrease in the
HIPK1
2/2 B1 B cell population, this is not the case. The B cell
phenotype observed in HIPK1
2/2 mice is similar to the phenotype
observed in the Fli-1
DCTA mice, which express a truncated Fli-1
lacking the C-terminal transcriptional activation domain [50].
Both strains have a diminished FO B population in the presence of
an increased MZ B cell population, with an unperturbed peritoneal
B1 population. The preservation of the B1 population in both of
these genetic models may reflect adaptation to reduced B cell
numbers consistent with the ‘‘production bottleneck’’ hypothesis.
Perhaps the most striking aspect of the HIPK1
2/2 immune
phenotype is the impaired response to the TI-2 antigen TNP-
Ficoll. HIPK1
2/2 mice harbour a greater number of MZ B cells
compared to wild-type controls, which would suggest a normal or
heightened response to TI-2 antigens. However, HIPK1
2/2 MZ B
cells, though abundant in number, were hyporesponsive to TNP-
Ficoll. This may reflect the impaired BCR-responsiveness that is
driving commitment to the MZ subset. The function of the
marginal zone macrophages may be impaired in the absence of
HIPK1, contributing to the hyporesponsiveness to TNP-Ficoll, and
requires further study. Previous reports have demonstrated that in
the absence of HIPK family members, proliferative capacity is
impaired [23,39,53]. Iacovelli et al. reported that HIPK2 is
undetectable in resting human peripheral blood lymphocytes, but
is reactivated in proliferating cells. Depletion of HIPK2 in immor-
talized human fibroblasts and mammary cells by siRNA resulted in
greatly impaired proliferation and induction of p21
waf-1/Cip-1, with
similar findings in primary murine BM cells [53]. Thus, HIPK2
expression is positively associated with cell proliferation. The data
presentedinthis reportfurther supportsa positive role for the HIPK
family in non-damaging, cell proliferation in lymphocytes.
Since HIPKs regulate a number of transcription factors, the B
cell phenotype observed in the HIPK1
2/2 mice may be due to a
failure to optimally execute the B cell transcriptional program.
Such transcriptional dysregulation may result in a switch towards
MZ B cell commitment or loss of expression of genes required for
optimal BCR signaling. The HIPKs are transcriptional co-
regulators that can activate or repress the expression of specific
target genes via phosphorylation of transcription factors and co-
factors. The HIPKs have been shown to interact with several
transcription factors and co-factors including p53, PAX6,
RUNX1, Brn3, NK3, Tcf3 and c-Myb, Groucho, CtBP1, p300,
CBP, c-Ski, Smad 1–4, MeCP2 and HMGA1 [6,19,20,23,
24,26,29,54–57]. In the case of c-Myb, HIPK1 interacts with
both the N- and C-terminal ends of c-Myb, making it plausible for
HIPK1 to influence c-Myb transcriptional activity in multiple
ways. Tissue-specific inactivation of c-Myb in mouse B cells has
demonstrated that c-Myb is involved in multiple stages of B
lymphopoiesis, including the maintenance of normal splenic B cell
homeostasis and proliferation [58,59].
The HIPK family, originally identified as transcriptional co-
repressors [15], are now known to regulate myriad cellular
functions including embryonic development, cell survival in adult
tissues, proliferation and differentiation. This study is the first to
report a role for HIPK in splenic B cell homeostasis and activation.
Supporting Information
Figure S1 HIPK1
2/2 mice exhibit normal splenic T1 B
cell viability. To detect active caspase 3 in T1 B cells, total
splenocytes were isolated from HIPK1
+/+ and HIPK1
2/2 mice and
immediately incubated with FITC-DEVD-FMK (EMDBios-
ciences, Mississauga, ON) according to the manufacturer’s
instructions. The splenocytes were then stained with B220,
CD23, and CD21, and 95000 total events were acquired. Cells
that were B220+, CD232, and CD212 were considered to be T1
B cells, and were measured for active caspase 3. The FACS plots
are representative plots. The average percentage from three
independent experiments, each done in triplicate, are shown in the
bar graph.
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